Lawrence Silverman
Pediatric Endocrinology · Morristown, NJNPI 1336113653
Payments from drug & device makers
Across 1,432 payments — averaging $642.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$268K
- OPKO Pharmaceuticals, LLC$229K
- Pfizer$146K
- Biomarin Pharmaceutical Inc.$89K
- Ascendis Pharma Endocrinology Inc$61K
- Tolmar, Inc.$46K
- plus $81K from 26 others
Across 33 payments — averaging $989.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$33K
What the payments were for
- Consulting fees$313,69064%
- Speaking & faculty fees$137,09328%
- Travel & lodging$33,7627%
- Food & beverage$6,9321%
- Education$2900%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 1,114 | $267,519 |
| OPKO Pharmaceuticals, LLC | 20 | $228,705 |
| Pfizer(2 entities) | 78 | $145,531 |
| Biomarin Pharmaceutical Inc. | 46 | $89,487 |
| Ascendis Pharma Endocrinology Inc | 28 | $61,223 |
| Tolmar, Inc. | 17 | $45,884 |
| Novo Nordisk Health Care AG | 7 | $27,199 |
| Novo Nordisk | 40 | $21,187 |
| Tolmar Pharmaceuticals, Inc. | 22 | $16,055 |
| Endo Pharmaceuticals Inc. | 9 | $7,208 |
| AbbVie | 5 | $3,935 |
| Ferring Pharmaceuticals Inc. | 8 | $2,861 |
| Vistapharm, Inc. | 1 | $1,800 |
| Sanofi-aventis U.S. LLC | 4 | $269 |
| Medtronic(2 entities) | 8 | $159 |
| Dexcom, Inc. | 4 | $75 |
| Johnson & Johnson | 2 | $59 |
| Insulet Corporation | 3 | $58 |
| Abbott | 3 | $51 |
| Soleno Therapeutics, Inc. | 1 | $25 |
| AstraZeneca | 1 | $21 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
| Travere Therapeutics, Inc. | 1 | $19 |
| BETA Bionics, Inc. | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Sequel Med Tech, LLC | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Lifescan, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NGENLA$89,666
- Rayaldee$49,218
- GENOTROPIN$35,812
- VOXZOGO 1.2mg$34,271
- FENSOLVI$26,932
- Norditropin$16,016
- SUPPRELIN$7,133
- SKYTROFA$6,252
- Sogroya$4,220
- ELIGARD$3,413
- ZOMACTON$2,558
- Thyquidity$1,800
- Lupron Depot$1,225
- TZIELD$109
How this compares
$919,501 in reported general payments places this provider in the 95th percentile of 59 pediatric endocrinology providers in New Jersey.
Other pediatric endocrinology in Morristown
- Barbara CerameMorristown$142K
- Kanika ShankerMorristown$39K
- Mansi KanhereMorristown$21K
- Aditi KhokharMorristown$6K
- Daisy ChinMorristown$1K
- Melissa WooMorristown$781
- Harold StarkmanMorristown$263
- Tejal PatelMorristown$146
- Ian MarshallNew Brunswick$165K
- Steven GhannyHackensack$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.